PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-02-08

Date Title Company
08-Feb-2022 Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells Kintara Therapeutics
08-Feb-2022 Amolyt Pharma Selected for the French Tech 120 Program Amolyt Pharma
08-Feb-2022 CORL Launches Innovative Medical Device Risk Assessment Toolkit Businesswire
08-Feb-2022 Iterative Scopes Announces AI-Driven Data Sharing Agreement with Pfizer to Advance IBD Clinical Trials Businesswire
08-Feb-2022 McKesson Designated by CMS as 2022 Qualified Clinical Data Registry Businesswire
08-Feb-2022 Rockley Photonics Announces Bioptx™ Biomarker Sensing Platform for Professional Healthcare, Including First-of-its-Kind Non-Invasive, Continuous Biosensing Wristband Businesswire
08-Feb-2022 AmerisourceBergen & Alliance Healthcare Executive Perspective Business Leaders on the Omicron Surge Alliance Healthcare
08-Feb-2022 DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development DuPont
08-Feb-2022 Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials Medidata
08-Feb-2022 Nanoform signs GMP manufacturing program with TargTex following formulation success Nanoform
08-Feb-2022 Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva® Businesswire
08-Feb-2022 Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease Tiziana Life Sciences Ltd
08-Feb-2022 Empagliflozin (Jardiance®) receives positive NICE recommendation for the treatment of symptomatic chronic heart failure with reduced ejection fraction Boehringer Ingelheim
08-Feb-2022 HUTCHMED Initiates Phase Ib/II Study of HMPL-453 in Combination with Chemotherapy or Toripalimab for Advanced Solid Tumors in China HUTCHMED
08-Feb-2022 Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy in Hemophilia B – Data Presented at EAHAD 2022 CSL Behring
08-Feb-2022 HealthCare.com® Extends Previously Announced $180M Financing with Additional $31.5M Investment from Hildred Capital Businesswire
08-Feb-2022 New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis Businesswire
08-Feb-2022 Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Businesswire
08-Feb-2022 Small Molecule Innovator CDMO Market Research Report 2022-2030 - ResearchAndMarkets.com Businesswire
08-Feb-2022 Cyclo Therapeutics Selected to Present Overview of Pivotal Phase 3 Study for Lead Candidate, Trappsol® Cyclo™, at WORLDSymposium 2022 Businesswire